We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
11
1 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
Completed
8
72.7%
Not yet recruiting
1
9.1%
Recruiting
Withdrawn
No approval data available
- A new peer-reviewed clinical study published in Biomedicines demonstrates that ProGo® Bioactive Peptides can simultaneously influence multiple biological drivers of healthy ageing, including iron metabolism, inflammation, glucose control, and body composition. - The study found that a single daily supplement of ProGo® produced effects not observed with a protein-matched comparator, suggesting unique bioactive properties beyond standard protein supplementation. - Hofseth BioCare ASA has released a companion white paper summarizing the clinical findings, while ProGo® was recently named winner in the Healthy Aging category at the 2025 NutraIngredients-USA Awards.